Company / Current Liabilities
Enveric Biosciences, Inc. Current Liabilities History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$14.7M
FY2019
5-year range
$14.7M / $30.4M
FY2017-FY2019
Trend
+0.0%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $30M to $15M over the past 2 years.
Based on SEC 10-K filings.
$15M in FY2019.
Improved from $30M to $15M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, current liabilities increased 0.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $14.7M | +0.0% |
| FY2018 | $14.7M | -51.6% |
| FY2017 | $30.4M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026